Breaking News Instant updates and real-time market news.

AMGN

Amgen

16:01
12/01/17
12/01
16:01
12/01/17
16:01

Amgen announces FDA approval of Repatha to prevent heart attack, stroke

Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. FDA approved Repatha as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease. The FDA also approved Repatha to be used as an adjunct to diet, alone or in combination with other lipid-lowering therapies, such as statins, for the treatment of adults with primary hyperlipidemia to reduce low density lipoprotein cholesterol.

  • 02

    Dec

  • 05

    Dec

  • 18

    Jan

  • 03

    Feb

  • 25

    Mar

  • 30

    Apr

  • 17

    May

  • 28

    May

AMGN Amgen

10/31/17
PIPR
10/31/17
NO CHANGE
Target $170
PIPR
Overweight
Piper says Amgen more credible biosimilar threat to Alexion in Europe
Piper Jaffray analyst Christopher Raymond believes Amgen's (AMGN) threat of a biosimilar alternative to Alexion Pharmaceuticals' (ALXN) Soliris may be more credible and near-term than he previously thought. The analyst highlights a Phase 3 study recently listed in the European Union's Clinical Trials Registry, which was authorized in August, as well as evidence of Amgen's active opposition to Alexion's intellectual property extension efforts in Europe. He reminds investors that two-thirds of Soliris' revenue is outside the U.S. Given this new evidence, "it would appear the real battleground may be Europe," Raymond tells investors in a research note. He keeps an Overweight rating on Alexion with a $170 price target. He views the company as well positioned to defend itself against Amgen.
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold from Buy at Argus
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold at Argus on secular slowdown in sales of top drugs
As reported earlier, Argus analyst David Toung downgraded Amgen to Hold from Buy, noting a "secular" slowdown in sales of the company's top three products - Enbrel, Neulasta and Aranesp. Toung says the sales of growth prospects Prolia, Kyprolis and Repatha are not yet large enough to offset the declines in the three established drugs which face generic competition after losing patent protection. The analyst notes that Amgen may not generate commercial revenue from biosimilars until 2019 due to regulatory and legal challenges.
11/29/17
PIPR
11/29/17
NO CHANGE
Target $190
PIPR
Overweight
Piper still bullish on Amgen after management meeting
Piper Jaffray analyst Christopher Raymond says he remains bullish on Amgen shares after hosting the company's management at his firm's healthcare conference. The analyst sees near-term pipeline catalysts from Amgen's immuno-oncology approach, which he sees coming more into focus, Repatha label expansion, Parsabiv launch and Aimovig approval/launch next year. Raymond maintains an Overweight rating on the shares with a $190 price target.

TODAY'S FREE FLY STORIES

VMC

Vulcan Materials

$122.21

-0.715 (-0.58%)

11:07
12/12/17
12/12
11:07
12/12/17
11:07
Conference/Events
Vulcan Materials management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.64

0.62 (4.13%)

11:05
12/12/17
12/12
11:05
12/12/17
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGU

Agrium

$110.72

2.71 (2.51%)

11:04
12/12/17
12/12
11:04
12/12/17
11:04
Hot Stocks
Agrium to acquire Louis Dreyfus Company's Macrofertil fertilizer business »

Agrium announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$47.72

-25.66 (-34.97%)

11:04
12/12/17
12/12
11:04
12/12/17
11:04
Upgrade
Spark Therapeutics rating change  »

Follow-up: Spark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 12

    Jan

GRPN

Groupon

$5.86

0.05 (0.86%)

10:57
12/12/17
12/12
10:57
12/12/17
10:57
Recommendations
Groupon analyst commentary  »

Groupon selloff today a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$51.62

0.19 (0.37%)

10:55
12/12/17
12/12
10:55
12/12/17
10:55
Options
Applied Materials put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

10:55
12/12/17
12/12
10:55
12/12/17
10:55
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

ONCE

Spark Therapeutics

$47.72

-25.66 (-34.97%)

10:54
12/12/17
12/12
10:54
12/12/17
10:54
Upgrade
Spark Therapeutics rating change  »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 12

    Jan

GSK

GlaxoSmithKline

$35.53

0.22 (0.62%)

10:53
12/12/17
12/12
10:53
12/12/17
10:53
Hot Stocks
FDA approves expanded use of GlaxoSmithKline's Nucala »

The FDA expanded the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TRIP

TripAdvisor

$35.32

0.82 (2.38%)

10:48
12/12/17
12/12
10:48
12/12/17
10:48
Hot Stocks
TripAdvisor, ReviewPush form licensing partnership for restaurant reviews »

ReviewPush announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$55.00

9.925 (22.02%)

, MS

Morgan Stanley

$53.09

0.32 (0.61%)

10:46
12/12/17
12/12
10:46
12/12/17
10:46
Hot Stocks
Overstock rises after Morgan Stanley discloses stake ahead of crypto launch »

Shares of Overstock…

OSTK

Overstock.com

$55.00

9.925 (22.02%)

MS

Morgan Stanley

$53.09

0.32 (0.61%)

BTC

Bitcoin

BITCOIN

Bitcoin

QVCA

QVC Group

$24.52

-0.27 (-1.09%)

TJX

TJX

$73.55

0.25 (0.34%)

COST

Costco

$188.86

0.79 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

ATVI

Activision Blizzard

$63.17

0.74 (1.19%)

, EA

Electronic Arts

$107.92

2.65 (2.52%)

10:44
12/12/17
12/12
10:44
12/12/17
10:44
Hot Stocks
Goldman ups Activision Blizzard, cuts EA in video game ratings shuffle »

Ahead of 2018, Goldman…

ATVI

Activision Blizzard

$63.17

0.74 (1.19%)

EA

Electronic Arts

$107.92

2.65 (2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

TMUS

T-Mobile

$63.07

0.53 (0.85%)

10:43
12/12/17
12/12
10:43
12/12/17
10:43
Conference/Events
T-Mobile to host business news update conference call »

T-Mobile's President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MMM

3M

$236.76

-2.54 (-1.06%)

10:43
12/12/17
12/12
10:43
12/12/17
10:43
Recommendations
3M analyst commentary  »

3M guidance solid versus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SQ

Square

$39.23

0.9318 (2.43%)

10:40
12/12/17
12/12
10:40
12/12/17
10:40
Options
Sizable put buyer in Square as shares rally »

Sizable put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Dec

WWE

WWE

$30.94

0.24 (0.78%)

10:37
12/12/17
12/12
10:37
12/12/17
10:37
Conference/Events
WWE management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

VKTX

Viking Therapeutics

$3.97

-0.11 (-2.70%)

10:35
12/12/17
12/12
10:35
12/12/17
10:35
Conference/Events
Viking Therapeutics management to meet with Maxim »

Meetingsto be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 28

    Dec

TSLA

Tesla

$328.91

13.78 (4.37%)

, PEP

PepsiCo

$117.97

0.58 (0.49%)

10:34
12/12/17
12/12
10:34
12/12/17
10:34
Hot Stocks
Tesla jumps as PepsiCo makes biggest public pre-order of Semi trucks »

Shares of Tesla (TSLA)…

TSLA

Tesla

$328.91

13.78 (4.37%)

PEP

PepsiCo

$117.97

0.58 (0.49%)

WMT

Walmart

$97.02

0.09 (0.09%)

DPSGY

Deutsche Post

$47.34

-0.26 (-0.55%)

JBHT

J.B. Hunt

$111.30

-1.21 (-1.08%)

BUD

AB InBev

$111.30

-0.12 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Jan

  • 20

    Feb

NICE

Nice

$87.68

-0.15 (-0.17%)

10:32
12/12/17
12/12
10:32
12/12/17
10:32
Conference/Events
Nice management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 26

    Feb

EA

Electronic Arts

$107.92

2.65 (2.52%)

10:30
12/12/17
12/12
10:30
12/12/17
10:30
Options
Electronic Arts attracts a bullish option play »

Electronic Arts attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

10:30
12/12/17
12/12
10:30
12/12/17
10:30
General news
Euro$ interest rate futures are lower »

Euro$ interest rate…

IPGP

IPG Photonics

$206.65

1.39 (0.68%)

10:29
12/12/17
12/12
10:29
12/12/17
10:29
Conference/Events
IPG Photonics management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EVI

EnviroStar

$31.45

0.85 (2.78%)

10:25
12/12/17
12/12
10:25
12/12/17
10:25
Hot Stocks
EnviroStar declares 12c per share special cash dividend »

EnviroStar announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

KMT

Kennametal

$45.81

-0.15 (-0.33%)

10:25
12/12/17
12/12
10:25
12/12/17
10:25
Conference/Events
Kennametal to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RPD

Rapid7

$18.77

0.03 (0.16%)

10:24
12/12/17
12/12
10:24
12/12/17
10:24
Conference/Events
Rapid7 to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.